📰 Precision Vaccines Program News
Page 4 - Precision Vaccines Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Precision Vaccines Program. Real-time updates on events, politics, business and more.
April 11, 2024
There is no evidence that mRNA Covid vaccines cause fatal cardiac arrest or other deadly heart problems in teens and young adults, a CDC report finds.
January 18, 2024
A University of Alberta professor is co-leading a new international vaccine safety network to examine why some people who received a COVID-19 vaccine experienced very rare adverse events associated with the vaccine.
October 24, 2023
<p>Flu season is upon us, and existing vaccines are only ~40-60% effective at reducing the risk of serious illness.&nbsp;The <a href="https://www.childrenshospital.org/research/departments/pediatrics-research/precision-vaccines-program">Precision Vaccines Program</a> (PVP) at Boston Children&rsquo;s Hospital was awarded a Vaccine Adjuvant Development Program contract (75N93023C00040) from the National Institutes of Health (NIH)/National Institute of Allergy an...
September 28, 2023
/PRNewswire/ -- Inimmune, a leading biotech company focused on the development of novel vaccine adjuvants, immunotherapies and delivery systems, announced...
September 12, 2023
The Food and Drug Administration on Monday greenlighted updated Covid boosters from Pfizer and Moderna. The shots, which are formulated to target the XBB.1.5 subvariant, are expected to be available
September 11, 2023
(NBC NEWS) - The Food and Drug Administration on Monday greenlighted updated Covid boosters from Pfizer and Moderna. The shots, which are formulated to target the XBB.1.5 subvariant, are expected
August 19, 2023
(CTN News) - It has been shown that the decision of whether to receive vaccinations in the left or right arm has a significant impact..........
August 18, 2023
Studys observational nature involved examination of immune reactions among approximately 300 individuals who had not contracted COVID-19
August 18, 2023
Studys observational nature involved examination of immune reactions among approximately 300 individuals who had not contracted COVID-19